The optimization of read more recombinant antibody production in Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Multiple strategies are employed maximize antibody titer, comprising process parameter optimization, media optimization, and the use of perfusion technologies. Fine-tuning media comp